Cases - Business

The finance industry is one of the largest sectors in most developed economies and as such offers many opportunities to build an exciting and rewarding career. One area which attracts much attention is investment banking
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
b>. It’s a high profile part of the industry because of the types of business that it specialises in – arranging stock market listings, mega-bond offerings and takeovers for businesses seeking financing and expansion. It is
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in
also one of the most lucrative areas in finance, commanding six figure salaries for first year. Accordingly, investment banking is a magnet for those seeking high flying careers. This article, part one of a three part serie
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

explores the investment banking industry including the good, the bad and the ugly.

Part one discusses some of the advantages and attractions of working in investment banking.

It’s in the money! Of course one of the top attra
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ctions for many is the potential money that comes attached to jobs in the industry. The industry demands a lot from the people that work in it both in ability and commitment. To attract top talent, the industry rolls out la
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro
ge pay packets. Bulge bracket firms such as Goldman Sachs, Morgan Stanley and Merrill Lynch can pay more than six figures for b-school grads. On top of that, there are sign-on and year-end bonuses that can double, triple or
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
generate even higher multiples of base salary. At senior levels the compensation reaches even higher levels of the stratosphere – managing directors can expect as much as mid-seven figures in good years.

Another allure is
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
the fast paced action on offer. There’s never a dull moment as an investment banker. The work involved in arranging share sales, bond offerings, acquisitions and sales of entire businesses is fast paced and complex where de
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ails and variables can change rapidly with movements in the markets. This presents a huge challenge for those delivering the goods and ensures that life is almost always moving quickly.

The prestige factor can also be attrac
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ive to some. The nature of the business often involves working with major public and private sector organisations, particularly at the leading investment banks. Deals can include initial public offerings of major industry p
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ayers and soon-to-be market leaders. Depending on the industry and location, transactions can also be industry changing events such as privatisations of state controlled entities.

As an investment banker there is always the
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a
opportunity to meet and interact with senior people. Not only is this an opportunity to better understand how top people in a given industry think and operate, it can present opportunities at many points along the career pa
dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod
h. On top of private sector contacts, there may also be interaction with senior government officials, especially in countries where the state maintains a high level of investment an industry. These all important connections
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
can prove useful.

For those that are attracted to leadership and responsibility, investment banks do not disappoint. The rapid pace of the industry means that those progressing through the ranks can be given significant leve
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ls of responsibility. It is quite normal for those in their mid-thirties to be responsible for entire business units. Investment banking is a big plus for those that like to be boss, although it must be noted that there are
t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
many levels of management within the larger banks.

Finally, a career as an investment banker can offer the opportunity for extensive travel, whether it is between cities within the country or as is more and more common, ac
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
oss international borders. As bankers progress through VP and Managing Director levels, there is the requirement to spend more time cultivating and developing client relationships. Often this is done in different cities and
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
different global locations. It can be exciting as well as enlightening to experience the different cultures and places located outside of your doorstep.

And there it is some of the main attractions for signing up as an inve
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
tment banker – money, travel, action, prestige, leadership and high level connections. Listed together these almost sound like a clich? for the original role of James Bond and perhaps explains why many ambitious graduates are
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
so interested in pursuing investment banking careers.

In part two, the flipside is discussed. Yes, there is a downside. Find out the negatives of life as an investment banker "Investment Banking Questions II – is it for you?

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Cases - Investment Banking Career Questions – Is It Really For You

Related Articles: